Skip to main content

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

 

Minimally Invasive Biopsy Technologies Market

Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market. However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030.

Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chronix Biomedical, Datar Cancer Genetics Limited, Owlstone Medical, Veracyte, Inc., LungLife AI, Inc., and Exosome Diagnostics, among others. are providing diversified range of product offerings for its effective management. Hence, the segment holds a dominating share in global minimally invasive biopsy technologies market.

Request For Free Sample: https://bisresearch.com/industry-report/minimally-invasive-biopsy-technologies-market.html

Europe is expected to witness maximum growth at a CAGR of 15.40%, during the forecast period 2019-2030. The growth in the region can be attributed to the rising number of funding and investments for research on minimally invasive biopsy technologies and also to the increasing cancer burden. For instance, the European Union’s research and innovation programme, Horizon 2020, awarded $6.94 million to a joint consortium on liquid biopsy and Magnetic Resonance Imaging. The initiative aims at analyzing the effects of liquid biopsy and MRI in the diagnosis of breast and colon cancer.

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

ADAS and Autonomous Driving Component Market

As per the recent BIS Research report, the ADAS and autonomous driving component market is segmented into component type, level of autonomy, vehicle type, and region for the purpose of study. These segments are further sub-segmented into various categories. In case of market by component type, it is sub-segmented into camera, radar, ultrasonic sensors, LiDAR, and ECU. The use of LiDAR is increasing rapidly in the market owing to reducing cost of LiDAR sensors and their greater range.
Post a Comment
Read more

Driving and Inhibiting Factors of Single Cell Sequencing Market

  A paradigm shift in the dynamics of the market is expected to be witnessed around 2029 with the introduction of imaging solutions and single cell automated system in full scale. The leading players in the market are undertaking the necessary steps to tackle the shift in dynamics and sustain the competition. The global single cell sequencing market is divided into two main categories, instruments and consumables. Kits and consumables market share was valued at $727.2 million of the global single cell sequencing market value in 2018. Also, the kits and consumables is expected to witness impressive growth. The sub-segment is expected to grow with a CAGR of 15.67% during the forecast period 2019-2029. This reflects the dependency of single cell sequencing market on consumables, which is expected to continue to grow in the future. Single cell sequencing workflow is majorly divided into three segments: single cell isolation, single cell preparation, and single cell analysis. Prese...
Post a Comment
Read more